Drive Wealth Management LLC Increases Stock Holdings in Haleon PLC Sponsored ADR $HLN

Drive Wealth Management LLC raised its stake in Haleon PLC Sponsored ADR (NYSE:HLN) by 438.3% during the 2nd quarter, HoldingsChannel reports. The firm owned 74,517 shares of the company’s stock after acquiring an additional 60,675 shares during the period. Drive Wealth Management LLC’s holdings in Haleon were worth $773,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Hanson & Doremus Investment Management boosted its stake in shares of Haleon by 234.1% in the second quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after buying an additional 1,662 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its stake in shares of Haleon by 135.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after buying an additional 1,491 shares in the last quarter. Banque Transatlantique SA purchased a new stake in shares of Haleon in the first quarter valued at approximately $27,000. Ransom Advisory Ltd purchased a new stake in shares of Haleon in the first quarter valued at approximately $31,000. Finally, Deutsche Bank AG boosted its stake in shares of Haleon by 267.8% in the first quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock valued at $32,000 after buying an additional 2,276 shares in the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. The Goldman Sachs Group upgraded Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. Wall Street Zen downgraded Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Barclays cut Haleon from an “overweight” rating to an “equal weight” rating in a report on Tuesday, September 16th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $12.33.

Haleon Stock Performance

NYSE HLN opened at $9.48 on Monday. Haleon PLC Sponsored ADR has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The stock has a market cap of $42.22 billion, a price-to-earnings ratio of 24.31, a price-to-earnings-growth ratio of 2.77 and a beta of 0.20. The business has a fifty day moving average of $9.41 and a 200-day moving average of $9.99. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48.

Haleon Increases Dividend

The business also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Stockholders of record on Friday, August 15th were issued a $0.0555 dividend. This represents a dividend yield of 190.0%. This is a positive change from Haleon’s previous semi-annual dividend of $0.05. The ex-dividend date of this dividend was Friday, August 15th. Haleon’s payout ratio is presently 28.21%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.